Upper GI Flashcards
What is the IHC profile of HCC vs cholangiocarcinoma
HCC:
Positive: Cam 5.2, HepPar-1, Albumin ISH, AFP (50%), CEA (pattern of positivity specific)
Negative: AE1/AE3neg (an exception to normal rule of carcinomas being positive), CK20/CK7
Cholangio:
Positive: AE1/AE3, cam5.2, CK20/CK7, CEA ( pattern of positivity specific)
Negative: HepPar1, albumin ISH (but positive in intrahepatic cholangio), AFP
What is the epidemiology and risk factors for HCC
Males >. Females
Leading cause of cancer mortality worldwide
Higher incidence in areas with high rates of hep b/c
Risk factors:
Hep b/c infection (80% of cases)
Injected drug use
Liver Cirrhosis
Obesity
Diabetes
Smoking
Alcohol use
Haemochromatosis
What is the typical presentation of HCC
Painless liver mass, without symptoms directly related to cancer
More likely to have signs and symptoms of underlying liver disease
-Cancer related: pain, weight loss, early satiety, diarrhoea, fever, fatigue
-decompensated cirhosis: ascites, encephalopathy, jaundice, variceal bleeding
Associated paraneoplastic syndromes including cutaneous; worse prognosis
What are the typical epidemiological features and risk factors for cholangiocarcinoma
No definite age predisposition
Present age 50-70
Higher rates south east Asia eg Thailand.
Risk factors:
-Primary sclerosing cholangitis (younger age of presentation). Lifetime risk 5-20%
-hepatobiliary lithiasis
-Liver flukes
-cystic fibrosis
-Le Fraumeni
-smoking
-hep b/c
-cirrhosis
-inflammatory bowel disease
-obesity, diabetes (also risk factors for HCC)
What are the microscopic features of cholangiocarcinoma
Usually adenocarcinoma
Significant peritumoural desmoplasia (lower yield of biopsy)
Typically multi focal
High rates of perineural invasion
Polysomy on FISH
What are prognostic factors for cholangiocarcinoma, what is the5yr survival
Age, stage, grade, margin status.
2-30% 5yr OS
What are the most common metastatic sites for cholangiocarcinoma
Liver, lung, peritoneum, bone
What blood tests should be done for a suspected liver cancer
Hep b/c (both, more HCC)
CEA (both)
CA19-9 (CCA)
AFP (HCC)
CBC
Coagulation screen (PT/INR)
Albumin
Liver enzymes, bilirubin
What scoring system is used for liver cirrhosis and what are it’s components?
Child’s Pugh
-total score groups into class A, B, C. C is worst class
-total bilirubin
-serum albumin
-PT or INR
-ascites (absent, moderate, severe)
-encephalopathy
What are the American screening recommendations for HCC
Anyone with chronic hep b infection and/or cirrhosis. Unless Child’s Pugh C and NOT on transplant list (ie prognosis too poor to warrant screening)
6 monthly USSand AFP
What is the microscopic appearance of hepatocellular carcinoma
May be one or several discrete lesions, or diffusely infiltrating the liver
Macroscopically pale or yellow (fatty) or green due to bile. May invade veins
Well/moderately differentiated: cells resembling hepatocytes, marked cellular atypia in poorly differentiated
Thick plates or trabeculae, pseudoglandular structures.
What is a typical presentation of cholangiocarcinoma
Presents early with small tumours due to signs and symptoms of biliary tract obstruction
Intrahepatic can present later, usually in individuals without liver cirrhosis. RUQ pain, weight loss.
1/3 have nodal Mets at diagnosis
What are the typical microscopic features of cholangiocarcinoma
Typically well to moderately differentiated
Adenocarcinoma features
Glandular/tubular structures lined by malignant epithelial cells
Abundant fibrous stroma
LVSI, PNI common
What imaging is used in the work up of hepatocellular carcinoma
MRI or
4 phase CT: pre contrast, hepatic arterial phase, portal venous phase, delayed phase
What are prognostic factors for hepatocellular carcinoma
Child’s Pugh score
Performance status
Stage
Metastatic disease
What does IPMN stand for, and where in the pancreas are they most commonly located. What is its radiological appearance
Intraductal papillary mucinous neoplasm
Head of pancreas, either in the main pancreatic duct or it’s branches
Cystic appearance on imaging (solid more concerning for invasive malignancy)
What are the three subtypes of IPMN
Gastric
Intestinal
Pancreatobiliary
Based on the appearance of the cells
What is the pre invasive lesion that is most commonly a precursor to pancreatic ductal adenocarcinoma
Pancreatic intraepithelial neoplasia (PanIN)
What is the most common pancreatic tumour
Pancreatic ductal adenocarcinoma
Where in the pancreas is pancreatic ductal adenocarcinoma most commonly located
The head of pancreas
What is the typical microscopic appearance of a pancreatic ductal adenocarcinoma
Well to moderately differentiated
Duct-like glandular structures that haphazardly infiltrate
Desmoplasia
PNI in 90%
LVSI in 50%
What does squamous differentiation mean for prognosis of pancreatic ductal adenocarcinoma
Worse prognosis
What four key driver gene mutations are commonly associated with pancreatic ductal adenocarcinoma, which is highly specific
KRAS (>90%)
p53 (50-80%)
p16 (CDKN2A) (95%)
SMAD4 (50%) highly specific
Ie these are molecular tests that can be done
What is the definition of a pancreatic neuroendocrine microadenoma
Well differentiated NET
<5mm
Non-functional
No mitoses
Benign and often incidental
What two inherited genetic syndromes are most associated with pancreatic NETs
MEN1
VHL
What is the prognosis of an unresectable pancreatic ductal adenocarcinoma
<1 year
What are the names of the exocrine cells and endocrine cells of the pancreas
Exocrine: serous actinic cells
Endocrine: islets of langerhans. Alpha cells: glucagon, beta cells: insulin, delta cells: somatostatin
What are the epidemiological patterns of pancreatic cancer
Male 1.3:1
Peak incidence 60-70
What are risk factors for pancreatic cancer
Chronic pancreatitis
Alcohol
Smoking
Red meat
Chronic diabetes
High BMI
Familial:
-hereditary pancreatitis
-PJS
-FAMMM
-BRCA 2
-Lynch
-ataxia telangiectasia
If screening for individuals with hereditary conditions increasing risk of pancreatic cancer, what are the best investigations?
EUS: highest sensitivity
MRI/MRCP
No consensus on management pathway once a lesion is detected, age to initiate/ terminate screening